Medically reviewed by Christopher Lee, MD Coronary artery disease (CAD) occurs when there's a blockage in the arteries that ...

The global coronary artery bypass graft market, valued at USD 17,612.1 million in 2023, is forecast to experience significant growth, reaching an estimated USD 22,765.9 million by 2033. While the ...

USA: A recent editorial comment in the Journal of the American College of Cardiology: Cardiovascular Imaging highlights the ...

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ...

The adverse consequences of stable coronary artery disease (CAD) are death, myocardial infarction (MI) and angina. Trials in stable CAD show that percutaneous coronary intervention (PCI) does not ...

Alembic Pharmaceuticals received final USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, designed to treat hypertension. Available in multiple strengths, these capsules ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first ...

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

Objectives This study aimed to assess the performance of carotid ultrasound (US) parameters alone or in combination with Framingham Risk Score (FRS) in discriminating patients with psoriatic arthritis ...

New microscopic particles could hold key to preventing cardiovascular diseases. Read more at straitstimes.com.